Literature DB >> 23574807

Synthesis, antidepressant evaluation and docking studies of long-chain alkylnitroquipazines as serotonin transporter inhibitors.

Mari Gabrielsen1, Karol Wołosewicz, Anna Zawadzka, Jerzy Kossakowski, Gabriel Nowak, Małgorzata Wolak, Katarzyna Stachowicz, Agata Siwek, Aina W Ravna, Irina Kufareva, Lech Kozerski, Elżbieta Bednarek, Jerzy Sitkowski, Wojciech Bocian, Ruben Abagyan, Andrzej J Bojarski, Ingebrigt Sylte, Zdzisław Chilmonczyk.   

Abstract

Twelve alkyl analogues (1-12) of the high-affinity serotonin transporter (SERT) inhibitor 6-nitroquipazine (6-NQ) were synthesized and studied using in vitro radioligand competition binding assays to determine their binding affinity (Ki ). The putative antidepressant activity of five of the binders with the highest SERT binding affinities was studied by the forced swim and locomotor activity mouse tests. The three-dimensional (3D) structures of 8 and 9 were determined using NOE NMR technique. Flexible docking of the compounds was undertaken to illustrate the binding of the compounds in the SERT model. Our results showed that several of the 6-NQ analogues are high-affinity SERT inhibitors and indicated that the octyl (8), decyl (10) and dodecyl (12) 6-NQ analogues exhibit moderate antidepressant activity.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23574807      PMCID: PMC3665732          DOI: 10.1111/cbdd.12116

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  45 in total

Review 1.  A functional-phylogenetic classification system for transmembrane solute transporters.

Authors:  M H Saier
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  Nuclear hormone receptor targeted virtual screening.

Authors:  Matthieu Schapira; Ruben Abagyan; Maxim Totrov
Journal:  J Med Chem       Date:  2003-07-03       Impact factor: 7.446

Review 3.  Pharmacology of rapid-onset antidepressant treatment strategies.

Authors:  P Blier
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

4.  Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.

Authors:  M J Owens; D L Knight; C B Nemeroff
Journal:  Biol Psychiatry       Date:  2001-09-01       Impact factor: 13.382

5.  Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines.

Authors:  Byoung Se Lee; Soyoung Chu; Bon-Su Lee; Dae Yoon Chi; Yun Seon Song; Changbae Jin
Journal:  Bioorg Med Chem Lett       Date:  2002-03-11       Impact factor: 2.823

6.  Serotonin transporter inhibitors: synthesis and binding potency of 2'-methyl- and 3'-methyl-6-nitroquipazine.

Authors:  J M Gerdes; S C DeFina; P A Wilson; S E Taylor
Journal:  Bioorg Med Chem Lett       Date:  2000-12-04       Impact factor: 2.823

7.  Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition.

Authors:  E M Adkins; E L Barker; R D Blakely
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

8.  Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter.

Authors:  Johan Sandell; Meixiang Yu; Patrick Emond; Lucette Garreau; Sylvie Chalon; Kjell Någren; Denis Guilloteau; Christer Halldin
Journal:  Bioorg Med Chem Lett       Date:  2002-12-16       Impact factor: 2.823

9.  Further conventions for NMR shielding and chemical shifts (IUPAC Recommendations 2008).

Authors:  Robin K Harris; Edwin D Becker; Sonia M Cabral De Menezes; Pierre Granger; Roy E Hoffman; Kurt W Zilm
Journal:  Magn Reson Chem       Date:  2008-06       Impact factor: 2.447

10.  Synthesis of a fluorine-18-labelled derivative of 6-nitroquipazine, as a radioligand for the in vivo serotonin transporter imaging with PET.

Authors:  Mylène Karramkam; Frédéric Dollé; Héric Valette; Laurent Besret; Yann Bramoullé; Françoise Hinnen; Françoise Vaufrey; Carine Franklin; Sébastien Bourg; Christine Coulon; Michèle Ottaviani; Marcel Delaforge; Christian Loc'h; Michel Bottlaender; Christian Crouzel
Journal:  Bioorg Med Chem       Date:  2002-08       Impact factor: 3.641

View more
  3 in total

1.  Derivatives of a new heterocyclic system - pyrano[3,4-c][1,2,4]triazolo[4,3-a]pyridines: synthesis, docking analysis and neurotropic activity.

Authors:  Ervand G Paronikyan; Anthi Petrou; Maria Fesatidou; Athina Geronikaki; Shushanik Sh Dashyan; Suren S Mamyan; Ruzanna G Paronikyan; Ivetta M Nazaryan; Hasmik H Hakopyan
Journal:  Medchemcomm       Date:  2019-06-19       Impact factor: 3.597

2.  Computational and biological evidences on the serotonergic involvement of SeTACN antidepressant-like effect in mice.

Authors:  Mariana G Fronza; Lucimar M Pinto Brod; Angela Maria Casaril; Manoela Sacramento; Diego Alves; Lucielli Savegnago
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

3.  Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands.

Authors:  Jarosław Walory; Lidia Mielczarek; Małgorzata Jarończyk; Mirosława Koronkiewicz; Jerzy Kossakowski; Ryszard Bugno; Andrzej J Bojarski; Zdzisław Chilmonczyk
Journal:  Int J Mol Sci       Date:  2018-10-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.